Literature DB >> 18591622

Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations.

Alessandro M Vannucchi, Paola Guglielmelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18591622     DOI： 10.3324/haematol.13266

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Diagnosis and Management of Polycythemia Vera: Proceedings from a Multidisciplinary Roundtable.

Authors:  Lisa A Raedler
Journal:  Am Health Drug Benefits       Date:  2014-10

2.  JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with Treatment.

Authors:  Alessandro M Vannucchi; Lisa Pieri; Paola Guglielmelli
Journal:  Ther Adv Hematol       Date:  2011-02

3.  Targeted deep sequencing in primary myelofibrosis.

Authors:  Ayalew Tefferi; Terra L Lasho; Christy M Finke; Yoseph Elala; Curtis A Hanson; Rhett P Ketterling; Naseema Gangat; Animesh Pardanani
Journal:  Blood Adv       Date:  2016-11-30

Review 4.  JAK2 mutation and thrombosis in the myeloproliferative neoplasms.

Authors:  Alessandro M Vannucchi
Journal:  Curr Hematol Malig Rep       Date:  2010-01       Impact factor: 3.952

Review 5.  Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia.

Authors:  Alessandro M Vannucchi
Journal:  Intern Emerg Med       Date:  2009-09-30       Impact factor: 3.397

6.  JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.

Authors:  Margarida Coucelo; Gonçalo Caetano; Teresa Sevivas; Susana Almeida Santos; Teresa Fidalgo; Celeste Bento; Manuela Fortuna; Marta Duarte; Cristina Menezes; M Letícia Ribeiro
Journal:  Int J Hematol       Date:  2013-11-26       Impact factor: 2.490

Review 7.  Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.

Authors:  Alessandro M Vannucchi; Paola Guglielmelli; Alessandro Rambaldi; Costanza Bogani; Tiziano Barbui
Journal:  J Cell Mol Med       Date:  2009-06-11       Impact factor: 5.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.